Chelsea Therapeutics (CHTP) Balance Sheet

Click line-items for a historical chart and %

Assets
Cash and cash equivalents	37.09M
Short-term investments
Prepaid contract research and manufacturing	624.99K
Other prepaid expenses and other current assets	618.78K
Total current assets	38.33M
Property and equipment, net	28.5K
Other assets
Total Assets	39.86M
Liabilities and Stockholders' Equity
Accounts payable	1.7M
Accrued compensation and related expenses	448.12K
Accrued contract research and manufacturing	204.04K
Other accrued expenses	1.58M
Total liabilities	3.97M
Commitments	0
Stockholders' equity:
Preferred stock, $0.0001 par value, 5,000,000 shares authorized, no shares issued and outstanding	0
Common stock, $0.0001 par value, 100,000,000 shares authorized, 61,847,700 and 49,790,975 shares issued and outstanding, respectively	7.85K
Additional paid-in capital	275.43M
Deficit accumulated during the development stage	-239.55M
Total stockholders' equity	35.89M
Total liabilities and stockholders' equity	39.86M

Entities mentioned with CHTP